ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Bears Pile In — but Chewy Shorts Retreat

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short sellers turned up the heat on several names this week while stepping back from a handful of heavily-shorted mid-caps.

Columbia Financial saw the biggest SI jump among stocks above $500M. Short interest hit 24.1% of free float — up nearly 7 percentage points in just seven days. That's a sharp move for a regional bank.

Wolfspeed remains one of the most-shorted mid-caps in the US. SI sits at 79.3% of free float and borrowing shares costs 7.7% APR. Availability is at zero — there are no shares left to borrow.

Dave Inc. also saw a notable rise. Short interest climbed to 26.6% of FF, up 3.6 points on the week.

SpaceX (SPCX), the publicly-traded private shares vehicle, now carries 29.7% short interest — up 3.6 points in a week. Analysts at Macquarie are calling it a "buy any dip" despite the bearish pressure.

On the other side, shorts are unwinding in ChronoScale Holdings. SI fell 10.3 points to 35.6% of FF — the biggest short-covering move of the week.

Chewy is seeing slow but steady short covering too. SI dropped 2.7 points to 65.8% of FF — still extreme, but the downward trend is notable. Availability is above 726%, meaning there is no shortage of borrow for those who want to add to positions.

The iShares S&P 500 Growth ETF (IVW) also caught attention today. Short interest jumped 32.6% in one week and borrowing costs nearly tripled — a sign some traders are hedging growth-stock exposure.

Stocks in this article

How this article was generated

Generated
21 Jul 2026, 16:06
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilization

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.